Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Modeling sequence - Sequence interactions for drug response
Min Lin
, Hongying Li
, Wei Hou
, Julie A. Johnson
, Rongling Wu
Department of Public Health Sciences
Division of Biostatistics and Bioinformatics
Penn State Cancer Institute
Cancer Institute, Cancer Control
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Modeling sequence - Sequence interactions for drug response'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug Response
100%
Sequence Interaction
100%
High Density
33%
Statistical Model
33%
Genetic Interaction
33%
Interaction Effect
33%
Heart Rate
33%
Single nucleotide Polymorphism
33%
Drug Discovery
33%
Dose Level
33%
Process-based
33%
Pharmacodynamics
33%
Single nucleotide Polymorphism Markers
33%
Dobutamine
33%
Pharmacogenetic Study
33%
Haplotype Structure
33%
Haplotype Mapping
33%
DNA Sequence Variants
33%
Genetic Etiology
33%
β-adrenergic Receptor
33%
Research Discovery
33%
Genetic Epistasis
33%
Adrenergic Receptors Subtypes
33%
Pharmacogenetics and Pharmacogenomics
33%
Complex Drug
33%
Pharmacodynamic Mechanism
33%
Interactive Network
33%
Biochemistry, Genetics and Molecular Biology
Drug Response
100%
Haplotype
66%
Single-Nucleotide Polymorphism
66%
Pharmacodynamics
66%
DNA Sequence
33%
Genetics
33%
Pharmacogenetics
33%
Gene Interaction
33%
Adrenergic Receptor
33%
Pharmacogenetic Testing
33%
Pharmacogenomics
33%
Haplotype Map
33%
Dobutamine
33%
Epistasis
33%
Neuroscience
Haplotype
100%
Single-Nucleotide Polymorphism
66%
Gene Interaction
33%
DNA Sequencing
33%
Receptor Subtype
33%
Dobutamine
33%
Beta Adrenergic Receptor
33%
Epistasis
33%